Blue Cloud Softech Solutions Limited has announced that its integrated healthcare-technology platforms have received endorsements from the Commonwealth Medical Association (CMA) and the Indian Medical Association (IMA), marking a major milestone in its global expansion ambitions.
The Hyderabad-based firm, which trades on the BSE under the code 539607, said it plans to roll out its full healthcare-ecosystem — comprising BluBio, BluHealth and Bioster across Commonwealth nations.
BluHealth is described as a comprehensive, AI-enabled digital health ecosystem combining non-invasive AI screening (via face-scan technology), an IoT-enabled “BluHealth Scanner” for real-time diagnostics, clinic- and hospital-management software (BluClinics / HIMS), and tools for both urban and rural health-care delivery. The company says this will allow accessible, scalable healthcare delivery across diverse settings.
BluBio is a precision-diagnostics and biobanking infrastructure. According to company claims, the biobank holds more than 150,000 unique specimens — including rare-disease samples and population-specific genetic variants — enabling advanced pathology, molecular diagnostics, genomic testing and research. The platform aims to support participation in global clinical trials, population-specific diagnostics and precision medicine.
Bioster, the third component of the offering, is presented as an advanced nano-photocatalytic air and surface purification system. Designed initially with healthcare facilities in mind, it is said to continuously neutralize pathogens, volatile organic compounds and pollutants in air and on surfaces — making it suitable not just for hospitals (including ICUs and operating rooms) but potentially for wider institutional, commercial and residential applications globally.
The combined market opportunity across the Commonwealth for these products spans an estimated US$957 billion. This includes markets for digital health platforms, diagnostics and biobanking, environmental safety and sterilization, hospital systems, telemedicine, and large-scale public health infrastructure.
With these endorsements from CMA and IMA, Blue Cloud Softech appears to be positioning itself as a provider of end-to-end healthcare infrastructure. from early detection and diagnostics to hospital-level care and environmental safety with ambitions to impact healthcare delivery across a large chunk of the global population.
